Published in Nature on August 19, 1986
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol (1992) 5.19
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J Virol (1991) 3.94
Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev (1992) 3.60
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol (1990) 3.35
Amplification and detection of lentiviral DNA inside cells. Proc Natl Acad Sci U S A (1990) 3.22
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62
Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc Natl Acad Sci U S A (1989) 2.21
Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol (2002) 2.05
Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol (1991) 1.93
Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol (1987) 1.92
Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J Virol (1990) 1.90
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol (1992) 1.85
Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1991) 1.83
Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci U S A (1993) 1.79
Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J Virol (1993) 1.77
Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 1.76
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol (1991) 1.75
GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci U S A (1989) 1.73
HIV-1 associated dementia: symptoms and causes. Retrovirology (2006) 1.70
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Replication and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate with in vivo pathogenicity. J Virol (1987) 1.64
The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J Virol (1987) 1.63
Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proc Natl Acad Sci U S A (1989) 1.61
Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J Virol (1988) 1.58
Role of the host immune response in selection of equine infectious anemia virus variants. J Virol (1987) 1.56
Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A (1990) 1.55
A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron (2009) 1.48
Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins. J Virol (1991) 1.41
Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. Am J Pathol (1995) 1.39
Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J Virol (1998) 1.38
Genetic structure and function of an early transcript of visna virus. J Virol (1988) 1.37
HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med (2012) 1.34
Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J Virol (1987) 1.33
HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis (2010) 1.32
Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys. J Virol (2008) 1.30
Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus). J Clin Microbiol (1989) 1.30
Monocyte maturation controls expression of equine infectious anemia virus. J Virol (1994) 1.29
Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells. J Virol (1988) 1.29
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol (1996) 1.27
The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J Exp Med (1987) 1.23
Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol (2012) 1.23
Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat. J Virol (1988) 1.22
CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. Proc Natl Acad Sci U S A (1992) 1.20
Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. Proc Natl Acad Sci U S A (1990) 1.19
Expression of HIV in lymph node cells of LAS patients. Immunohistology, in situ hybridization, and identification of target cells. Am J Pathol (1988) 1.16
Early molecular replication of human immunodeficiency virus type 1 in cultured-blood-derived T helper dendritic cells. J Clin Invest (1993) 1.13
Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues. Am J Pathol (1995) 1.09
Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol (1992) 1.08
Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus. J Virol (1991) 1.08
Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest (2000) 1.07
Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro. J Cell Biol (1990) 1.06
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol (1994) 1.04
The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J Virol (1989) 1.04
Infectious agents and neurodegeneration. Mol Neurobiol (2012) 1.03
Selective replication of simian immunodeficiency virus in a subset of CD4+ lymphocytes. Proc Natl Acad Sci U S A (1989) 1.03
Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc Natl Acad Sci U S A (1989) 1.01
Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol (1990) 1.00
Nuclear import of the retrotransposon Tf1 is governed by a nuclear localization signal that possesses a unique requirement for the FXFG nuclear pore factor Nup124p. Mol Cell Biol (2000) 0.99
Expression of viral antigens in the central nervous system of visna-infected sheep: an immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence. Acta Neuropathol (1989) 0.98
Structural and functional analysis of the visna virus Rev-response element. J Virol (1992) 0.97
Synovial lymphocytes and the aetiology of synovitis. Ann Rheum Dis (1993) 0.97
HIV-1 and the hijacking of dendritic cells: a tug of war. Springer Semin Immunopathol (2005) 0.96
Microculture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells. J Clin Microbiol (1990) 0.96
Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory. Neurobiol Dis (2012) 0.96
The NF-kappa B binding site is necessary for efficient replication of simian immunodeficiency virus of macaques in primary macrophages but not in T cells in vitro. J Virol (1993) 0.93
Analysis of antibody responses to phenotypically distinct lentiviruses. J Clin Microbiol (1990) 0.90
Efficient production of human immunodeficiency virus proteins in transgenic mice. J Virol (1992) 0.90
Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo. Am J Pathol (1991) 0.90
Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques. J Virol (2016) 0.90
The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells. J Virol (1991) 0.89
Small ruminant lentivirus genetic subgroups associate with sheep TMEM154 genotypes. Vet Res (2013) 0.88
Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. J Virol (1993) 0.86
Pattern of transcription of the genome of equine infectious anemia virus. J Virol (1990) 0.86
The inside out of lentiviral vectors. Viruses (2011) 0.85
HIV Associated Neurocognitive Disorders. Infect Dis Rep (2013) 0.84
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope. Retrovirology (2014) 0.84
Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc Natl Acad Sci U S A (1997) 0.84
The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo. J Virol (1995) 0.84
Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus. Proc Natl Acad Sci U S A (1987) 0.83
Persistent infection of rabbits with bovine immunodeficiency-like virus. J Virol (1992) 0.83
Phenotypic analysis of lymphocyte populations in the lungs and regional lymphoid tissue of sheep naturally infected with maedi visna virus. Clin Exp Immunol (1992) 0.83
Initial lentivirus-host interactions within lymph nodes: a study of maedi-visna virus infection in sheep. J Virol (1995) 0.82
Cerebral astrocytoma in association with HIV infection. J Neurol Neurosurg Psychiatry (1988) 0.81
Epitope analysis of capsid and matrix proteins of North American ovine lentivirus field isolates. J Clin Microbiol (1991) 0.81
Genetic variation and HIV-associated neurologic disease. Adv Virus Res (2013) 0.81
STAT1 pathway is involved in activation of caprine arthritis-encephalitis virus long terminal repeat in monocytes. J Virol (1997) 0.80
Small ruminant lentiviruses (SRLVs) break the species barrier to acquire new host range. Viruses (2013) 0.80
Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides. Antimicrob Agents Chemother (1987) 0.80
Activation of caprine arthritis-encephalitis virus long terminal repeat by gamma interferon. J Virol (1996) 0.80
Vaccine and antiviral strategies against infections caused by human immunodeficiency virus. CMAJ (1988) 0.80
Contribution of CNS cells in NeuroAIDS. J Pharm Bioallied Sci (2010) 0.79
Proteomic biosignatures for monocyte-macrophage differentiation. Cell Immunol (2011) 0.79
Origin of HIV. BMJ (1989) 0.79
Regulation of the reverse transcriptase of human immunodeficiency virus type 1 by dNTPs. Proc Natl Acad Sci U S A (1992) 0.79
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci U S A (1978) 7.95
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55
The slow infection caused by visna virus. Curr Top Microbiol Immunol (1975) 2.99
Slow persistent infection caused by visna virus: role of host restriction. Science (1977) 2.83
Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci U S A (1984) 2.73
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis (2001) 2.63
Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol (1991) 2.47
Visna DNA synthesis and the tempo of infection in vitro. Virology (1982) 2.47
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A (1997) 2.11
Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. Science (1985) 2.09
Gene expression in visna virus infection in sheep. Nature (1981) 1.98
Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol (2000) 1.92
Antigenic variation in visna virus. Cell (1979) 1.81
The structural polypeptides of RNA slow viruses. Virology (1974) 1.81
Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci U S A (1993) 1.79
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis (2000) 1.51
Visna virus DNA: discovery of a novel gapped structure. Virology (1981) 1.51
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48
Visna virus RNA synthesis. J Virol (1977) 1.48
Measles virus nucleotide sequences: detection by hybridization in situ. Science (1981) 1.45
Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc Natl Acad Sci U S A (1991) 1.45
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet (1984) 1.42
Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog (1987) 1.39
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A (1983) 1.37
Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna. Virology (1985) 1.27
Isolation of replication-competent molecular clones of visna virus. Virology (1991) 1.26
Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. Mucosal Immunol (2008) 1.22
Serological definition of the lentivirus group of retroviruses. J Virol (1979) 1.20
Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest (1999) 1.19
Demonstration of a DNA provirus in the lytic growth of visna virus. Nat New Biol (1973) 1.18
A comparison of the high molecular weight RNAs of visna virus and Rous sarcoma virus. Virology (1974) 1.18
Detection of visna virus antigens and RNA in glial cells in foci of demyelination. Virology (1985) 1.17
Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon. J Virol (1969) 1.16
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1999) 1.16
Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1985) 1.14
Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDS. J Infect Dis (1997) 1.13
Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol (1996) 1.12
Inhibition of RNA slow viruses by thiosemicarbazones. Biochem Biophys Res Commun (1973) 1.09
Infectivity of visna virus DNA. Virology (1976) 1.09
Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proc Natl Acad Sci U S A (1996) 1.04
The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease. Microb Pathog (1987) 1.04
The purification of adenovirus neutralizing antibody: adenovirus type 5 hexon immunoadsorbent. J Immunol (1972) 1.01
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res Hum Retroviruses (2000) 1.00
Quantitative analysis of visna virus replication in vivo. Virology (1985) 1.00
Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution. J Virol (1998) 0.98
Increased expression of heat shock protein, transferrin, and beta 2-microglobulin in astrocytes during scrapie. Microb Pathog (1993) 0.97
Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts. J Intern Med (2009) 0.97
Increased monokines in cytomegalovirus infected myelomonocytic cell cultures. Microb Pathog (1989) 0.96
Induction of interferon in lymphoblastoid cell lines. Proc Soc Exp Biol Med (1970) 0.96
The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue. J Virol (1997) 0.95
Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology (1995) 0.95
Detection by hybridization of viral infection of the human central nervous system. Ann N Y Acad Sci (1984) 0.92
Measles virus genome in infections of the central nervous system. J Infect Dis (1981) 0.92
Induction of immunity in man by crystalline adenovirus type 5 capsid antigens. Proc Soc Exp Biol Med (1973) 0.92
The Chediak-Higashi syndrome: continuous suspension cultures derived from peripheral blood. Blood (1969) 0.91
In situ amplification of visna virus DNA in tissue sections reveals a reservoir of latently infected cells. Microb Pathog (1991) 0.90
Field trials of methisazone as a prophylactic agent against smallpox. Am J Epidemiol (1971) 0.90
A new approach to investigating the relationship between productive infection and cytopathicity in vivo. Nat Med (1997) 0.88
Double-label techniques of in situ hybridization and immunocytochemistry. Curr Top Microbiol Immunol (1989) 0.88
Nucleotide sequence of a cDNA encoding mouse cathepsin D. Nucleic Acids Res (1990) 0.87
Interferon production in cell lines derived from patients with infectious mononucleosis. Proc Soc Exp Biol Med (1968) 0.86
Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells. AIDS Res Hum Retroviruses (2000) 0.85
Potential for the transmission of HIV-1 despite highly active antiretroviral therapy. N Engl J Med (1998) 0.84
Integration of visna virus DNA occurs and may be necessary for productive infection. Virology (1997) 0.83
Speculations on the role of transmissible agents in the pathogenesis of Alzheimer's disease. Can J Neurol Sci (1986) 0.83
Outpatient biopsies of the palatine tonsil: access to lymphoid tissue for assessment of human immunodeficiency virus RNA titers. Otolaryngol Head Neck Surg (1996) 0.83
Analysis of viral infections by in situ hybridization. J Histochem Cytochem (1986) 0.83
The pathogenesis of slow virus infections: molecular analyses. J Infect Dis (1986) 0.82
Detection of viral genes and their products in chronic neurological diseases. Ann Neurol (1984) 0.82
Combined macroscopic and microscopic detection of viral genes in tissues. Virology (1985) 0.81
Characterization of the nucleic acid product of the visna virus RNA dependent DNA polymerase. Virology (1974) 0.81
Human herpes virus infections and Alzheimer's disease. Neuropathol Appl Neurobiol (1990) 0.81
A national tissue bank to track HIV eradication and immune reconstruction. Science (1998) 0.80
Polyoma virus-human cell interactions: persistence of T-antigen in two cell lines with and without transformation. J Virol (1978) 0.80
RNA splice site utilization by simian immunodeficiency viruses derived from sooty mangabey monkeys. Virology (1996) 0.80
Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans. Arch Pathol Lab Med (1998) 0.80
Quantitative image analysis of simian immunodeficiency virus replication in macrophages coinfected with Mycobacterium avium complex. J Infect Dis (2000) 0.80
The rev gene of visna virus is required for productive infection. Virology (1994) 0.79
Laboratory diagnosis of hepatitis B virus infection by nucleic acid hybridization analyses and immunohistologic detection of gene products. Dev Biol Stand (1985) 0.78
Increased expression of nitric oxide synthase and dendritic injury in simian immunodeficiency virus encephalitis. J Hum Virol (1999) 0.77
Detection of herpes virus genome in Alzheimer's disease by in situ hybridization: a preliminary study. J Neural Transm Suppl (1987) 0.76
The immunogenicity of adenovirus type 5 structural proteins. J Immunol (1972) 0.76
Proviral load and expression of avian leukosis viruses of subgroup C in long-term persistently infected heterologous hosts (ducks). Arch Virol (1999) 0.75
Proceedings: The visna provirus and slow virus disease. Neurology (1975) 0.75
Deletion in the prion protein gene in a demented patient. Hum Mol Genet (1992) 0.75
Adenovirus type 12 oncogenicity in newborn hamsters. The effect of pokeweed mitogen. J Immunol (1968) 0.75
Sequence analysis of human T cell lymphotropic virus type I (HTLV-I) Env genes amplified from central nervous system tissues of patients with HTLV-I-associated myelopathy or leukemia. Microb Pathog (1995) 0.75